Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1558
-
Total 13F shares, excl. options
-
1,024,922,600
-
Shares change
-
+4,501,812
-
Total reported value, excl. options
-
$77,180,332,612
-
Value change
-
+$357,307,777
-
Put/Call ratio
-
1.14%
-
Number of buys
-
679
-
Number of sells
-
-805
-
Price
-
$75.39
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2018
1,762 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q1 2018.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,558 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,024,922,600 shares
of 1,240,722,841 outstanding shares and own 82.61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (105,236,053 shares), VANGUARD GROUP INC (95,079,078 shares), STATE STREET CORP (53,913,342 shares), Capital Research Global Investors (42,943,339 shares), Bank of New York Mellon Corp (27,715,531 shares), FMR LLC (24,694,890 shares), PARNASSUS INVESTMENTS /CA (19,710,860 shares), PRICE T ROWE ASSOCIATES INC /MD/ (17,419,309 shares), GEODE CAPITAL MANAGEMENT, LLC (17,027,568 shares), and NORTHERN TRUST CORP (16,497,946 shares).
This table shows the top 1558 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.